Holdings
Ally Bridge Group (NY) LLC
As of Jun 30, 2026, Ally Bridge Group (NY) LLC reported 22 positions worth US$75.1M. Largest: Minerva Neurosciences, Inc, Promis Neurosciences Inc. and First Tracks Biotherapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Minerva Neurosciences, Inc | 2.18M | US$12.1M | +520K | Jun 30, 2026 |
| Promis Neurosciences Inc. | 620K | US$8.16M | +206K | Jun 30, 2026 |
| First Tracks Biotherapeutics, Inc. | 284K | US$5.72M | new | Jun 30, 2026 |
| Axsome Therapeutics, Inc. | 16,493 | US$4.04M | new | Jun 30, 2026 |
| Assembly Biosciences, Inc. | 140K | US$3.85M | new | Jun 30, 2026 |
| Whitehawk Therapeutics, Inc. | 818K | US$3.75M | no change | Jun 30, 2026 |
| Edgewise Therapeutics, Inc. | 83,300 | US$3.38M | −77,700 | Jun 30, 2026 |
| Climb Bio, Inc. | 249K | US$3.25M | new | Jun 30, 2026 |
| Kura Oncology, Inc. | 290K | US$3.18M | new | Jun 30, 2026 |
| Cytomx Therapeutics, Inc. | 775K | US$2.91M | −125K | Jun 30, 2026 |